Cellectar Biosciences Price to Sales Ratio 2010-2024 | CLRB
Historical PS ratio values for Cellectar Biosciences (CLRB) over the last 10 years. The current P/S ratio for Cellectar Biosciences as of May 02, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cellectar Biosciences P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-05-02 |
0.27 |
|
0.00 |
| 2024-12-31 |
0.30 |
0 |
0.00 |
| 2024-09-30 |
2.14 |
0 |
0.00 |
| 2024-06-30 |
2.50 |
0 |
0.00 |
| 2024-03-31 |
3.98 |
0 |
0.00 |
| 2023-12-31 |
2.77 |
0 |
0.00 |
| 2023-09-30 |
2.64 |
0 |
0.00 |
| 2023-06-30 |
1.95 |
0 |
0.00 |
| 2023-03-31 |
1.43 |
0 |
0.00 |
| 2022-12-31 |
1.71 |
0 |
0.00 |
| 2022-09-30 |
3.36 |
0 |
0.00 |
| 2022-06-30 |
4.04 |
0 |
0.00 |
| 2022-03-31 |
6.88 |
0 |
0.00 |
| 2021-12-31 |
6.64 |
0 |
0.00 |
| 2021-09-30 |
9.25 |
0 |
0.00 |
| 2021-06-30 |
11.90 |
0 |
0.00 |
| 2021-03-31 |
16.10 |
0 |
0.00 |
| 2020-12-31 |
20.80 |
0 |
0.00 |
| 2020-09-30 |
12.40 |
0 |
0.00 |
| 2020-06-30 |
12.80 |
0 |
0.00 |
| 2020-03-31 |
13.33 |
0 |
0.00 |
| 2019-12-31 |
22.50 |
0 |
0.00 |
| 2019-09-30 |
20.00 |
0 |
0.00 |
| 2019-06-30 |
21.80 |
0 |
0.00 |
| 2019-03-31 |
23.50 |
0 |
0.00 |
| 2018-12-31 |
15.50 |
0 |
0.00 |
| 2018-09-30 |
30.00 |
0 |
0.00 |
| 2018-06-30 |
62.00 |
0 |
0.00 |
| 2018-03-31 |
113.50 |
0 |
0.00 |
| 2017-12-31 |
137.00 |
0 |
0.00 |
| 2017-09-30 |
167.00 |
0 |
0.00 |
| 2017-06-30 |
163.00 |
0 |
0.00 |
| 2017-03-31 |
227.00 |
0 |
0.00 |
| 2016-12-31 |
122.00 |
0 |
0.00 |
| 2016-09-30 |
271.00 |
0 |
0.00 |
| 2016-06-30 |
344.00 |
0 |
0.00 |
| 2016-03-31 |
341.83 |
0 |
0.00 |
| 2015-12-31 |
735.00 |
0 |
0.00 |
| 2015-09-30 |
1970.00 |
0 |
0.00 |
| 2015-06-30 |
2880.00 |
0 |
0.00 |
| 2015-03-31 |
3110.00 |
0 |
0.00 |
| 2014-12-31 |
3090.00 |
0 |
0.00 |
| 2014-09-30 |
2220.00 |
0 |
0.00 |
| 2014-06-30 |
6390.00 |
0 |
0.00 |
| 2014-03-31 |
7800.00 |
0 |
0.00 |
| 2013-12-31 |
7400.00 |
0 |
0.00 |
| 2013-09-30 |
7200.00 |
0 |
0.00 |
| 2013-06-30 |
9200.00 |
0 |
0.00 |
| 2013-03-31 |
9210.00 |
0 |
0.00 |
| 2012-12-31 |
14800.00 |
0 |
0.00 |
| 2012-09-30 |
21000.00 |
0 |
0.00 |
| 2012-06-30 |
23800.00 |
0 |
0.00 |
| 2012-03-31 |
17000.00 |
0 |
0.00 |
| 2011-12-31 |
8800.00 |
0 |
0.00 |
| 2011-09-30 |
25400.00 |
0 |
0.00 |
| 2011-06-30 |
26000.00 |
0 |
0.00 |
| 2011-03-31 |
54468.00 |
0 |
0.00 |
| 2010-12-31 |
79254.00 |
0 |
0.00 |
| 2010-09-30 |
159120.00 |
0 |
0.00 |
| 2010-06-30 |
321300.00 |
0 |
0.00 |
| 2010-03-31 |
556920.00 |
0 |
0.00 |
| 2009-12-31 |
1000000.00 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.012B |
$0.000B |
|
Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin.
|
